Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

50%(1 trials)

Terminated

1(17%)

Phase Distribution

Ph phase_2

33%

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 2Efficacy & side effects

2(33.3%)

N/ANon-phased studies

4(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

2 of 6 finished

Non-Completion Rate

66.7%

4 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(4)

Detailed Status

Withdrawn3

Completed2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 2

Trials by Phase

Phase 22 (33.3%)

N/A4 (66.7%)

Trials by Status

completed233%

terminated117%

withdrawn350%

Recent Activity

0 active trials

Showing 5 of 6

terminatednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT03534141Not Applicable

Mild Hypothermia and Acute Kidney Injury in Liver Transplantation

Terminated

NCT01728649Not Applicable

Reperfusion With Cooling in Cerebral Acute Ischemia II

Withdrawn

NCT01890317Not Applicable

Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction

Completed

NCT02544256Not Applicable

Mild Hypothermia During Intracranial Aneurysm Clipping

Withdrawn

NCT02411877Phase 2

REperfusion With Cooling in CerebraL Acute IscheMia II

Withdrawn

NCT00282373Phase 2

Induction of Mild Hypothermia in Resuscitated Cardiac Arrest Patients

Completed

All 6 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 6